Caplin Point Laboratories informs about press release

03 Mar 2023 Evaluate
Caplin Point Laboratories has informed that it enclosed Press Release regarding grant of USFDA approval for its Abbreviated New Drug Application (ANDA) Rocuronium Bromide Injection to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

2478.80 -101.25 (-3.92%)
09-Jan-2025 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1827.00
Dr. Reddys Lab 1373.60
Cipla 1491.70
Lupin 2250.40
Zydus Lifesciences 1008.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.